HRTX - Heron Therapeutics GAAP EPS of -$0.63 misses by $0.15 revenue of $23.46M beats by $0.85M May, 09 2022 04:43 PM Heron Therapeutics Inc. Heron Therapeutics press release (NASDAQ:HRTX): Q1 GAAP EPS of -$0.63 misses by $0.15. Revenue of $23.46M (+17.2% Y/Y) beats by $0.85M. For further details see: Heron Therapeutics GAAP EPS of -$0.63 misses by $0.15, revenue of $23.46M beats by $0.85M